These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 24976709)

  • 1. Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease.
    Hu KC; Wang HY; Liu SC; Liu CC; Hung CL; Bair MJ; Liu CJ; Wu MS; Shih SC
    World J Gastroenterol; 2014 Jun; 20(24):7718-29. PubMed ID: 24976709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.
    Castera L; Friedrich-Rust M; Loomba R
    Gastroenterology; 2019 Apr; 156(5):1264-1281.e4. PubMed ID: 30660725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice.
    Zhou JH; Cai JJ; She ZG; Li HL
    World J Gastroenterol; 2019 Mar; 25(11):1307-1326. PubMed ID: 30918425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Sumida Y; Nakajima A; Itoh Y
    World J Gastroenterol; 2014 Jan; 20(2):475-85. PubMed ID: 24574716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiologic evaluation of nonalcoholic fatty liver disease.
    Lee SS; Park SH
    World J Gastroenterol; 2014 Jun; 20(23):7392-402. PubMed ID: 24966609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Fukusato T
    World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AGA Clinical Practice Update on the Role of Noninvasive Biomarkers in the Evaluation and Management of Nonalcoholic Fatty Liver Disease: Expert Review.
    Wattacheril JJ; Abdelmalek MF; Lim JK; Sanyal AJ
    Gastroenterology; 2023 Oct; 165(4):1080-1088. PubMed ID: 37542503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography.
    Tsai E; Lee TP
    Clin Liver Dis; 2018 Feb; 22(1):73-92. PubMed ID: 29128062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet?
    Alkhouri N; Feldstein AE
    Metabolism; 2016 Aug; 65(8):1087-95. PubMed ID: 26972222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.
    Stål P
    World J Gastroenterol; 2015 Oct; 21(39):11077-87. PubMed ID: 26494963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers in nonalcoholic fatty liver disease-the emperor has no clothes?
    Sanal MG
    World J Gastroenterol; 2015 Mar; 21(11):3223-31. PubMed ID: 25805928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date.
    Albhaisi S; Sanyal AJ
    Pharmaceut Med; 2019 Dec; 33(6):451-463. PubMed ID: 31933238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease and vascular disease: state-of-the-art.
    Fargion S; Porzio M; Fracanzani AL
    World J Gastroenterol; 2014 Oct; 20(37):13306-24. PubMed ID: 25309067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.
    Fitzpatrick E; Dhawan A
    World J Gastroenterol; 2014 Aug; 20(31):10851-63. PubMed ID: 25152587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic Fatty Liver Disease: Common Questions and Answers on Diagnosis and Management.
    Westfall E; Jeske R; Bader AR
    Am Fam Physician; 2020 Nov; 102(10):603-612. PubMed ID: 33179890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods.
    Yoneda M; Imajo K; Takahashi H; Ogawa Y; Eguchi Y; Sumida Y; Yoneda M; Kawanaka M; Saito S; Tokushige K; Nakajima A
    J Gastroenterol; 2018 Feb; 53(2):181-196. PubMed ID: 29177681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH).
    Drescher HK; Weiskirchen S; Weiskirchen R
    Cells; 2019 Aug; 8(8):. PubMed ID: 31394730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.
    Pacifico L; Bonci E; Marandola L; Romaggioli S; Bascetta S; Chiesa C
    World J Gastroenterol; 2014 Dec; 20(45):17107-14. PubMed ID: 25493023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods to improve the noninvasive diagnosis and assessment of disease severity in children with suspected nonalcoholic fatty liver disease (NAFLD): Study design.
    Rudolph B; Bjorklund N; Ovchinsky N; Kogan-Liberman D; Perez A; Liszewski M; Levin TL; Ewart M; Liu Q; Xue X; Viswanathan S; Strickler HD
    Contemp Clin Trials; 2018 Dec; 75():51-58. PubMed ID: 30401631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic Fatty Liver Disease: An Update on the Diagnosis.
    Zhang JZ; Cai JJ; Yu Y; She ZG; Li H
    Gene Expr; 2019 Nov; 19(3):187-198. PubMed ID: 31010457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.